Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Argus Health
Mallinckrodt
Federal Trade Commission
Express Scripts
Cerilliant
Covington
UBS

Generated: February 20, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for BUSPIRONE

« Back to Dashboard

Payment Methods and Pharmacy Types for BUSPIRONE (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $9,495,981
INSIDE ANOTHER STORE $58,085,018
[disabled in preview] $142,308,267
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 297,865
INSIDE ANOTHER STORE 2,987,180
[disabled in preview] 4,501,342
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $43,490,043
MEDICARE $43,339,597
[disabled in preview] $127,666,908
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for BUSPIRONE
Drug Units Sold Trends for BUSPIRONE

Annual Sales Revenues and Units Sold for BUSPIRONE

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2016
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2015
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2014
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2013
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2012
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2011
BUSPIRONE ➤ Try a Free Trial ➤ Try a Free Trial 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Harvard Business School
Queensland Health
Citi
AstraZeneca
Express Scripts
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.